Abstract
Pompe disease (PD) is a recessive metabolic disorder characterized by acid α-glucosidase (GAA) deficiency, which results in lysosomal accumulation of glycogen in all tissues, especially in skeletal muscles. PD clinical course is mainly determined by the nature of the GAA mutations. Although ~400 distinct GAA sequence variations have been described, the genotype-phenotype correlation is not always evident.
In this study, we describe the first clinical and genetic analysis of Colombian PD patients performed in 11 affected individuals. GAA open reading frame sequencing revealed eight distinct mutations related to PD etiology including two novel missense mutations, c.1106 T > C (p.Leu369Pro) and c.2236 T > C (p.Trp746Arg). In vitro functional studies showed that the structural changes conferred by both mutations did not inhibit the synthesis of the 110 kD GAA precursor form but affected the processing and intracellular transport of GAA. In addition, analysis of previously described variants located at this position (p.Trp746Gly, p.Trp746Cys, p.Trp746Ser, p.Trp746X) revealed new insights in the molecular basis of PD. Notably, we found that p.Trp746Cys mutation, which was previously described as a polymorphism as well as a causal mutation, displayed a mild deleterious effect. Interestingly and by chance, our study argues in favor of a remarkable Afro-American and European ancestry of the Colombian population. Taken together, our report provides valuable information on the PD genotype–phenotype correlation, which is expected to facilitate and improve genetic counseling of affected individuals and their families.
Competing interests: None declared
Authors MónicaYasmín Niño and Heidi Eliana Mateus contributed equally to this work.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Becker JA et al (Apr 1998) The African origin of the common mutation in African American patients with glycogen-storage disease type II. Am J Hum Genet 62(4): 991–994. ISSN 0002-9297. http://www.ncbi.nlm.nih.gov/pubmed/9529346
Beesley CE, Child AH, Yacoub MH (1998) The identification of five novel mutations in the lysosomal acid a-(1-4) glucosidase gene from patients with glycogen storage disease type II. Mutations in brief no. 134. Hum Mutat 11(5): 413. ISSN 1059-7794. http://www.ncbi.nlm.nih.gov/pubmed/10206684
Boerkoel CF et al (Apr 1995) Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 56(4): 887–897. ISSN 0002-9297. http://www.ncbi.nlm.nih.gov/pubmed/7717400
Chien YH et al (Jun 2011) Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening. J Pediatr 158(6): 1023–1027.e1. ISSN 1097-6833. http://www.ncbi.nlm.nih.gov/pubmed/21232767
Den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15(1): 7–12. ISSN 1059-7794. http://www.ncbi.nlm.nih.gov/pubmed/10612815
Hermans MM et al (1993) Two mutations affecting the transport and maturation of lysosomal alpha-glucosidase in an adult case of glycogen storage disease type II. Hum Mutat 2(4): 268–273. ISSN 1059-7794. http://www.ncbi.nlm.nih.gov/pubmed/8401535
Hirschhorn R, Reuser A (2001) Glycogen storage disease type II (GSDII). In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3389–3420
Huie ML et al (Dec 1994) Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13 T-- > G) mutation in a majority of patients and a novel IVS10 (+1GT-- > CT) mutation. Hum Mol Genet 3(12): 2231–2236. ISSN 0964-6906. http://www.ncbi.nlm.nih.gov/pubmed/7881425
Kishnani PS et al (May 2006) A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 148(5): 671–676. ISSN 0022-3476. http://www.ncbi.nlm.nih.gov/pubmed/16737883
Ko TM et al (1999) Molecular genetic study of Pompe disease in Chinese patients in Taiwan. Hum Mutat 13(5): 380–384. ISSN 1059-7794. http://www.ncbi.nlm.nih.gov/pubmed/10338092
Kroos MA et al (Jan 2007) Broad spectrum of Pompe disease in patients with the same c.-32-13 T- > G haplotype. Neurology 68(2): 110–115. ISSN 1526-632X. http://www.ncbi.nlm.nih.gov/pubmed/17210890
Kroos M et al (Jun 2008) Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating. Hum Mutat 29(6): E13–26. ISSN 1098-1004. http://www.ncbi.nlm.nih.gov/pubmed/18425781
Labrousse P et al (Apr 2010) Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. Mol Genet Metab 99(4): 379–383. ISSN 1096-7206. http://www.ncbi.nlm.nih.gov/pubmed/20080426
Laforêt P et al (Oct 2000) Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology 55(8): 1122–1128. ISSN 0028-3878. http://www.ncbi.nlm.nih.gov/pubmed/11071489
Li Y et al (Oct 2004) Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem 50(10): 1785–1796. ISSN 0009-9147. http://www.ncbi.nlm.nih.gov/pubmed/15292070
Montalvo AL et al (Mar 2004) Glycogenosis type II: identification and expression of three novel mutations in the acid alpha-glucosidase gene causing the infantile form of the disease. Mol Genet Metab 81(3): 203–208. ISSN 1096-7192. http://www.ncbi.nlm.nih.gov/pubmed/14972326
Müller-Felber W et al (Oct 2007) Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 17(9–10): 698–706. ISSN 0960-8966. http://www.ncbi.nlm.nih.gov/pubmed/17643989
Oba-Shinjo SM et al (Nov 2009) Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations. J Neurol 256(11): 1881–1890. ISSN 1432-1459. http://www.ncbi.nlm.nih.gov/pubmed/19588081
Palmer RE et al (Jan 2007) Pompe disease (glycogen storage disease type II) in Argentineans: clinical manifestations and identification of 9 novel mutations. Neuromuscul Disord 17(1): 16–22. ISSN 0960-8966. http://www.ncbi.nlm.nih.gov/pubmed/17056254
Pittis MG et al (Jun 2008) Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease. Hum Mutat 29(6): E27–36. ISSN 1098-1004. http://www.ncbi.nlm.nih.gov/pubmed/18429042
Raben N et al (1999) Novel mutations in African American patients with glycogen storage disease Type II. Mutations in brief no. 209. Hum Mutat 13(1): 83–84. ISSN 1059-7794. http://www.ncbi.nlm.nih.gov/pubmed/10189220
Raben N et al (Nov–Dec 2007) Deconstructing Pompe disease by analyzing single muscle fibers: to see a world in a grain of sand… Autophagy 3(6):546–552. ISSN 1554-8627. http://www.ncbi.nlm.nih.gov/pubmed/17592248.
Reuser AJ et al (Jun 1987) Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts. J Clin Invest 79(6): 1689–1699. ISSN 0021-9738. http://www.ncbi.nlm.nih.gov/pubmed/3108320
Sharma MC et al (2005) Delayed or late-onset type II glycogenosis with globular inclusions. Acta Neuropathol 110(2): 151–157. ISSN 0001-6322. http://www.ncbi.nlm.nih.gov/pubmed/15986226
Slonim AE et al (Jan 2007) Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 35(1): 70–77. ISSN 0148-639X. http://www.ncbi.nlm.nih.gov/pubmed/17022069
Sugawara K et al (Jun 2009) Structural modeling of mutant alpha-glucosidases resulting in a processing/transport defect in Pompe disease. J Hum Genet 54(6): 324–330. ISSN 1435-232X. http://www.ncbi.nlm.nih.gov/pubmed/19343043
van den Hout HM et al (Aug 2003) The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112(2): 332–340. ISSN 1098-4275. http://www.ncbi.nlm.nih.gov/pubmed/12897283
van der Ploeg AT, Reuser AJ (Oct 2008) Pompe’s disease. Lancet 372(9646): 1342–1353. ISSN 1474-547X. http://www.ncbi.nlm.nih.gov/pubmed/18929906
van der Ploeg A et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe’s disease. N Engl J Med 362(15):1396–1406. http://www.ncbi.nlm.nih.gov/pubmed/20393176
Wan L et al (Jun 2008) Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II. J Neurol 255(6): 831–838. ISSN 0340-5354. http://www.ncbi.nlm.nih.gov/pubmed/18458862
Acknowledgments
This work was supported by the Universidad del Rosario (Grant CS/Genetics) and by Genzyme Corporation, Colombia.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Robin Lachmann
Rights and permissions
Copyright information
© 2012 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Niño, M.Y. et al. (2012). Identification and Functional Characterization of GAA Mutations in Colombian Patients Affected by Pompe Disease. In: Brown, G., Morava, E., Peters, V., Gibson, K., Zschocke, J. (eds) JIMD Reports - Case and Research Reports, 2012/4. JIMD Reports, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2012_138
Download citation
DOI: https://doi.org/10.1007/8904_2012_138
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-32441-3
Online ISBN: 978-3-642-32442-0
eBook Packages: MedicineMedicine (R0)